Angel News
Angel News

Back to Homepage

13th January 2022

ProVerum raises €30M in Series A funding

ProVerum Limited, an Irish medical device company developing a minimally invasive solution to treat benign prostatic hyperplasia (BPH) in the doctor's office, has closed a €30 million Series A equity financing co-led by Gilde Healthcare Partners and Lightstone Ventures, including participation from existing investors.


Register / Login now to read full story

In order to read the full story we need you to be registered with us, please click the links below to login or register.

Login / Register

Add a comment:




Enter the characters in the image shown:

Back to Homepage